MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 216 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $785 | -99.8% | 3,240 | -32.2% | 0.08% | +52.9% |
| Q4 2021 | $405,000 | -44.6% | 4,780 | -47.8% | 0.05% | -31.1% |
| Q3 2021 | $731,000 | +50.1% | 9,156 | +83.0% | 0.07% | +34.5% |
| Q2 2021 | $487,000 | +31.3% | 5,003 | +50.1% | 0.06% | -9.8% |
| Q4 2020 | $371,000 | -66.7% | 3,334 | -72.8% | 0.06% | -53.1% |
| Q4 2019 | $1,115,000 | +251.7% | 12,241 | +232.9% | 0.13% | +202.3% |
| Q3 2019 | $317,000 | -33.4% | 3,677 | +116.0% | 0.04% | +79.2% |
| Q2 2018 | $476,000 | – | 1,702 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| University of Wisconsin Foundation | 73,487 | $17,003,422 | 28.29% |
| Tao Capital Management LP | 130,529 | $30,202 | 27.63% |
| Paulson & Co. | 1,105,741 | $255,846,353 | 23.09% |
| AlpInvest Partners B.V. | 211,488 | $48,934,093 | 11.18% |
| Bain Capital Life Sciences Investors, LLC | 324,619 | $75,110,344 | 7.20% |
| Avoro Capital Advisors LLC | 1,888,888 | $437,050,905 | 6.04% |
| Propel Bio Management, LLC | 30,032 | $6,948,804 | 5.76% |
| Baker Brothers Advisors | 1,969,798 | $455,771,861 | 5.19% |
| Rosalind Advisors, Inc. | 25,000 | $5,784,500 | 4.76% |
| TCG Crossover Management, LLC | 179,917 | $41,629,195 | 4.62% |